- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00004572
Identification and Therapy Efficacy of Type 2 Diabetes in Hispanic Patients
June 23, 2005 updated by: National Center for Research Resources (NCRR)
The two major types of diabetes are type 1 and type 2 diabetes.
Although most patients with type 2 diabetes are older than age 40, type 2 diabetes has been reported with increasing frequency among patients under the age of 20.
This form of diabetes has been called type 2 diabetes of youth, abbreviated type 2Y.
Little is known about the etiology of type 2Y; however, clinicians believe that it occurs most commonly in obese children of particular ethnic groups.
A positive family history appears to be one major risk factor for developing type 2Y diabetes.
The individual contribution of ethnicity, obesity, and genetics to type 2Y have yet to be elucidated.
There is no consensus regarding treatment with type 2Y diabetes.
Observation of our Hispanic patients in the Houston area reveals a large number with type 2Y.
The major purpose of this study is to examine the genetic and environmental risk factors such as family history, ethnicity, and obesity in Hispanic children with type 2Y diabetes.
SPECIFIC AIMS: 1) To examine the genetic and environmental risk factors and clinical signs associated with type 1 diabetes and type 2 diabetes of youth.
2) To compare the efficacy of the treatment modalities, insulin and oral agents, in type 2Y patients.
METHODS: We will undertake a retrospective case study, to include a review of hypothesized risk factors in all the medical records of pediatric diabetes patients seen at University of Texas.
We anticipate that approximately 200 patients with type 1 diabetes and 30 patients with type 2Y diabetes will be identified.
A Sustacal challenge test will be done in patients with a suspected diagnosis of type 2Y in order to confirm the clinical diagnosis.
Parents will be contacted by phone for a detailed pedigree intake.
Type 1 and type 2Y patients will be compared for each of the studied features.
A retrospective review of diabetes type 2 therapies used in type 2Y patients will be undertaken through further examination of the medical records in order to compare insulin treatment to oral agents.
We will also test a subset of the patients for the gene identified in adult Hispanics with type 2 diabetes.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Approximately 30 pediatric patients (ages 10-18) believed to have a diagnosis of type 2Y. Each subject must have been diagnosed for at least one year.
Exclusion Criteria:
- Patients over the age of 18 or under the age of 10
- Patients in whom intellectual functioning is impaired sufficiently to interfere with the understanding of the protocol.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
February 16, 2000
First Submitted That Met QC Criteria
February 16, 2000
First Posted (Estimate)
February 17, 2000
Study Record Updates
Last Update Posted (Estimate)
June 24, 2005
Last Update Submitted That Met QC Criteria
June 23, 2005
Last Verified
April 1, 2000
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NCRR-M01RR02558-0129
- M01RR002558 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.